Our analysis supports the concept that risk for hypoglycemia is greater in nonobese than in obese patients, regardless of type of basal insulin used.[21,22] The previous hypothesis about greater insulin deficiency and longer diabetes duration (both well-recognized risk factors for hypoglycemia)[21,22] may well account for this finding. The gene discussed is INS; the disease is Hypoglycemia.